絞り込み

16548

広告

Examination of burden of skeletal-related events in patients naive to denosumab and intravenous bisphosphonates therapy in bone metastases from solid tumors population.

著者 Bhowmik D , Song X , Intorcia M , Gray S , Shi N
Curr Med Res Opin.2018 Oct 05 ; ():1-24.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (20view , 0users)

Full Text Sources

Miscellaneous

Skeletal-related events (SREs), i.e. pathologic fractures, spinal cord compression, surgery and radiation to bone, are serious skeletal complications that occur frequently in patients with bone metastases (BM) from solid tumors (ST). Clinical guidelines recommend treatment with denosumab and intravenous bisphosphonates (IVBPs) to prevent SREs. However, therapy may be delayed by physicians due to perceived low risk of SREs or for other clinical reasons. This study estimated SRE incidence rates in treatment-naive (i.e., no denosumab or IVBPs) patients with BM from ST in the US.
PMID: 30286662 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード